1900 Wealth Management LLC Sells 37 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

1900 Wealth Management LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 675 shares of the healthcare conglomerate’s stock after selling 37 shares during the quarter. 1900 Wealth Management LLC’s holdings in UnitedHealth Group were worth $355,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Robbins Farley bought a new stake in UnitedHealth Group during the 3rd quarter worth $25,000. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $26,000. CGC Financial Services LLC raised its stake in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the period. NewSquare Capital LLC increased its holdings in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA grew its holdings in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Wells Fargo & Company dropped their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Morgan Stanley reduced their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday. Piper Sandler boosted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Finally, TD Cowen dropped their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Stock Down 0.6 %

UNH stock traded down $2.88 during trading on Tuesday, hitting $488.35. 1,364,439 shares of the company’s stock traded hands, compared to its average volume of 4,512,896. The firm has a market capitalization of $450.22 billion, a P/E ratio of 30.07, a PEG ratio of 1.38 and a beta of 0.54. The business has a fifty day simple moving average of $488.10 and a two-hundred day simple moving average of $515.03. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. During the same period last year, the firm earned $6.26 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group’s payout ratio is currently 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.